Literature DB >> 12829529

Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm control.

Christopher J Boos, Ranjit S More, Jorg Carlsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12829529      PMCID： PMC1126304          DOI： 10.1136/bmj.326.7404.1411

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study.

Authors:  E Bertaglia; D D'Este; F Zerbo; F Zoppo; P Delise; P Pascotto
Journal:  Eur Heart J       Date:  2002-10       Impact factor: 29.983

Review 4.  Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.

Authors:  E N Prystowsky; D W Benson; V Fuster; R G Hart; G N Kay; R J Myerburg; G V Naccarelli; D G Wyse
Journal:  Circulation       Date:  1996-03-15       Impact factor: 29.690

5.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation.

Authors:  I C Van Gelder; H J Crijns; R G Tieleman; J Brügemann; P J De Kam; A T Gosselink; F W Verheugt; K I Lie
Journal:  Arch Intern Med       Date:  1996 Dec 9-23

8.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Authors:  P A Wolf; T R Dawber; H E Thomas; W B Kannel
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

9.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Authors:  Jörg Carlsson; Sinisa Miketic; Jürgen Windeler; Alessandro Cuneo; Sebastian Haun; Stefan Micus; Sabine Walter; Ulrich Tebbe
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272
  10 in total
  6 in total

1.  Rate and rhythm are important in critically ill patients.

Authors:  Egbert Pravinkumar
Journal:  BMJ       Date:  2003-10-18

2.  A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation.

Authors:  C Boos; J Ritzema; R S More
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 3.  WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.

Authors:  John Cordina; Gillian E Mead
Journal:  Cochrane Database Syst Rev       Date:  2017-11-15

Review 4.  Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat.

Authors:  Cyrus R Kumana; Bernard M Y Cheung; Giselle T Y Cheung; Tori Ovedal; Bjorn Pederson; Ian J Lauder
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

5.  Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study.

Authors:  C L Hu; H Jiang; Q Z Tang; Q H Zhang; J B Chen; C X Huang; G S Li
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

6.  Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.

Authors:  Z R Yousef; S C Tandy; V Tudor; F Jishi; R J Trent; D K Watson; R P W Cowell
Journal:  Heart       Date:  2004-11       Impact factor: 5.994
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.